Detalhe da pesquisa
1.
Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults.
J Infect Dis;
228(9): 1253-1262, 2023 11 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37439701
2.
SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines.
Hum Vaccin Immunother;
20(1): 2301632, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38206168